Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Period
Forecast Period
The wood pulp costs have been climbing all through the year. Microcrystalline Cellulose is finally starting to show it clearly. The US prices led the group in the first half of 2026 (H1 2026), up by 2.6%, from a value of USD 2.79/KG from USD 2.72/KG in Q1. The firmer wood pulp and acid costs raised the conversion cash costs across the board. The sustained pharmaceutical and nutraceutical restocking added a second push on top. Globally the average moved from a value of USD 2.625/KG to USD 2.687/KG, a smaller but still real gain of 2.4 percent. For the second half of 2026 (H2 2026), a range of USD 2.70-2.95/KG looks like the right one. The pharmaceutical excipient demand and the firm pulp costs are both holding steady.
Microcrystalline Cellulose, or MCC, is what you get when the wood pulp goes through a controlled acid hydrolysis, then washing, spray drying, and milling to a specific particle size. What makes it valuable in the tablet manufacturing is a fairly rare combination. It binds well, disintegrates cleanly, and flows through the automated equipment without fuss, exactly what the direct-compression tableting needs. The pharmaceutical excipient use takes the largest share by far, functioning as a filler, binder, and disintegrant across the generic and branded drug formulations alike. The food industry use, texturising and stabilising, comes next in line. The cosmetic thickening and dental care binder applications fill out the smaller rest. The wood pulp and acid hydrolysis costs set the baseline. The conversion cash costs add on top of that. The pace of the pharmaceutical restocking determines how much of that gets passed through in any given quarter.
Steady, not dramatic, that's the setup heading into the second half of 2026 (H2 2026). The pharmaceutical and nutraceutical formulators kept restocking at a consistent pace through the H1, sustaining the baseline demand even as the port inventories sat at fairly routine levels. The wood pulp and acid hydrolysis costs firmed gradually across most of the producing regions. That's really the whole story behind the production floor moving up.
A wood pulp supply disruption, or a sharper acid cost increase, could push things above the range of it. A softer pharmaceutical restocking, or the wood pulp costs easing back, would pull the prices below it instead.
| Region | 2026 Price Range (USD/KG) | Outlook |
| Global Average | 2.70 - 2.95 | Pharmaceutical excipient demand and pulp cost support |
| United States | 2.79 - 3.05 | Excipient standardisation demand maintains premium |
| China | 2.62 - 2.86 | Large processing capacity keeps China most affordable |
| Germany | 2.72 - 2.97 | Strict quality standards support firm pricing |
| India | 2.67 - 2.92 | Growing pharmaceutical manufacturing supports firm middle |
The US prices rose by 2.6% to a value of USD 2.79/KG, the top of the entire tracked range. The pharmaceutical excipient standardisation demand kept growing steadily. The firmer wood pulp costs did the rest of it.
Why did the price of Microcrystalline Cellulose change in Q2 2026 in the United States?
Pharmaceutical excipient standardisation requirements kept restocking demand on a steady footing. Firmer wood pulp and acid costs raised conversion cash costs at the same time. Producers operated near full capacity, which at least kept supply availability from becoming a separate problem.
China remains the cheapest tracked market even after a rise of 2.3% to a value of USD 2.62/KG. The wood pulp and acid costs firmed further. The export demand from Southeast Asia added a bit of extra pull on top.
Why did the price of Microcrystalline Cellulose change in Q2 2026 in China?
Firmer wood pulp and acid costs raised conversion cash costs at processing facilities. Export demand from India and Southeast Asia supported quotations through the quarter. Producers running near full rates after preventive maintenance kept supply comfortable despite the increase.
Germany rose by 2.3% to a value of USD 2.72/KG. The strict quality standards for the pharmaceutical and nutraceutical grades are the constant here. They keep the European floor elevated regardless of what else is happening.
Why did the price of Microcrystalline Cellulose change in Q2 2026 in Germany?
Strict European quality standards for pharmaceutical-grade excipients kept production costs elevated. Sustained pharmaceutical and nutraceutical restocking added consistent demand on top. USD 2.72/KG is where the quarter closed.
India climbed by 2.3% to a value of USD 2.67/KG. A growing domestic pharmaceutical manufacturing capacity kept the demand firm. The wood pulp costs firmed alongside it, a fairly typical two-factor quarter for this market.
Why did the price of Microcrystalline Cellulose change in Q2 2026 in India?
Growing domestic pharmaceutical manufacturing capacity sustained firm procurement through the quarter. Wood pulp and acid processing costs firmed in line with broader input cost inflation. Export demand added a final layer of support near USD 2.67/KG.
The US prices rose by 1.5% to a value of USD 2.72/KG in Q1. Sustained pharmaceutical restocking. Firming wood pulp costs. Both in play, setting up the continued climb that followed in the Q2.
Why did the price of Microcrystalline Cellulose change in Q1 2026 in the United States?
Sustained pharmaceutical and nutraceutical restocking kept demand on a steady footing. Firming wood pulp and acid costs pushed the underlying cost base up. USD 2.72/KG is where things settled.
China's Q1 average rose by 1.6% to a value of USD 2.56/KG. The export demand from India and Southeast Asia stayed firm. The wood pulp costs firmed in tandem with it. Nothing especially dramatic here.
Why did the price of Microcrystalline Cellulose change in Q1 2026 in China?
Export demand from India and Southeast Asia stayed firm through the quarter. Firming wood pulp and acid costs pushed the production floor up modestly. Market advanced to USD 2.56/KG.
Germany rose by 1.5% to a value of USD 2.66/KG in Q1. The strict pharmaceutical-grade quality standards remain the constant factor here. The firming wood pulp costs added a bit more pressure on top of that.
Why did the price of Microcrystalline Cellulose change in Q1 2026 in Germany?
Strict pharmaceutical-grade quality standards kept production costs elevated through the quarter. Firming wood pulp and acid costs added further pressure. USD 2.66/KG is where the quarter closed.
India rose by 1.6% to a value of USD 2.61/KG in Q1. Growing pharmaceutical manufacturing demand. Firming wood pulp costs. Both supported the increase, setting the stage for the further gain that followed.
Why did the price of Microcrystalline Cellulose change in Q1 2026 in India?
Growing domestic pharmaceutical manufacturing demand lifted procurement through the quarter. Firming wood pulp and acid costs pushed the production floor up. That combination laid the groundwork for the further gain in Q2.
Steady and unspectacular, that's this climb across all six straight quarters, exactly what you'd expect from a market driven by a gradual wood pulp cost inflation rather than any acute shock. The global prices rose in every single quarter, from a value of USD 2.443/KG in Q1 2025 to USD 2.687/KG by Q2 2026, a cumulative gain of 10.0 percent. The wood pulp and acid hydrolysis cost cycles, with the steady pharmaceutical restocking activity alongside, account for nearly all of it.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 2.687 | +2.4% | ↑ Rising |
| Q1 2026 | 2.625 | +1.5% | ↑ Rising |
| Q4 2025 | 2.585 | +1.6% | ↑ Rising |
| Q3 2025 | 2.545 | +2.1% | ↑ Rising |
| Q2 2025 | 2.493 | +2.0% | ↑ Rising |
| Q1 2025 | 2.443 | - | - Stable |
MCC climbed steadily through the year 2025, supported by the firming wood pulp costs and the sustained excipient demand rather than anything unusual. The global average opened at a value of USD 2.443/KG in Q1, closed at USD 2.585/KG in Q4, a gain of 5.8 percent over the year. The growing pharmaceutical excipient standardisation requirements, with the firming acid hydrolysis processing costs alongside, drove the increase. No single quarter stood out as unusual here.
The US prices rose by 5.9% over the year, from a value of USD 2.53/KG to USD 2.68/KG. The pharmaceutical excipient standardisation demand, along with the firming wood pulp costs, both contributed throughout the year.
China matched the pace almost exactly, up by 5.9 percent, from a value of USD 2.38/KG to USD 2.52/KG. The steady export demand, along with the firming acid hydrolysis costs, drove the increase.
Germany posted the smallest gain of all four regions, at 5.6 percent, from a value of USD 2.48/KG to USD 2.62/KG. The strict pharmaceutical-grade quality standards were the constant behind the climb.
India rose by 5.8 percent, from a value of USD 2.43/KG to USD 2.57/KG, tracking the global average quite closely. A growing domestic pharmaceutical manufacturing capacity pushed the trend steadily higher.
Expert Market Research: Your Source for Real-Time Microcrystalline Cellulose Price Intelligence
Expert Market Research tracks the Microcrystalline Cellulose prices continuously, across every major producing and consuming region. The team traces the causation through the wood pulp and acid hydrolysis economics, the conversion cost cycles, and the shifting pharmaceutical and nutraceutical demand. Contact Expert Market Research today for the Microcrystalline Cellulose pricing data, a bespoke market analysis, and a strategic procurement advisory.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
The pharmaceutical excipient use accounts for the largest share, functioning as a filler, binder, and disintegrant in tablets and capsules. The food industry use as a texturiser and stabiliser, with the cosmetic thickener and dental care binder applications alongside, make up the rest.
The Q2 2026 prices come to a value of USD 2.79/KG in the United States, USD 2.62/KG in China, USD 2.72/KG in Germany, and USD 2.67/KG in India. The excipient standardisation demand keeps the United States at the top of the range.
The global average moved from a value of USD 2.585/KG in Q4 2025 to USD 2.625/KG in Q1 2026, then to USD 2.687/KG by Q2, a gain of 2.4 percent across the half-year. The firming wood pulp costs, along with the sustained pharmaceutical restocking, drove the increase.
The sustained pharmaceutical and nutraceutical restocking kept the baseline demand steady across all major markets. The firmer wood pulp and acid hydrolysis costs raised the conversion cash costs at the same time. The export demand from India and Southeast Asia added further support to it.
A range of USD 2.70 to 2.95/KG looks like the right one for the rest of the year 2026, assuming the pharmaceutical excipient demand stays firm and the wood pulp costs hold at current levels.
The United States sits the highest, owing to the excipient standardisation demand. Germany carries a premium tied to the strict quality standards. India occupies a firm middle, owing to the growing pharmaceutical manufacturing. China remains the cheapest, thanks to its processing scale.
Monthly. Reach out to the Expert Market Research team directly for real-time pricing intelligence.
The wood pulp and acid hydrolysis costs sit at the core of it, with the conversion cash costs at the processing facilities close behind. The pharmaceutical and nutraceutical restocking cycles matter too, and the port inventory levels or the producer operating rates can move the prices at the margin.
China leads on this, owing to its extensive wood pulp processing capacity, exporting substantial volumes to India and other markets. India follows as the largest importer, with the European and North American producers serving the pharmaceutical-grade demand domestically.
Timing the excipient contracts around the pharmaceutical and nutraceutical production cycles helps quite a bit. The wood pulp and acid hydrolysis costs give the clearest early signal for where the production floor is heading, worth watching given how consistently the restocking demand has supported the prices.
Basic Report -
One Time
Basic Report -
Annual Subscription
Detailed Report -
One Time
Detailed Report -
Annual Subscription
Basic Report -
One Time
USD 799
tax inclusive*
Basic Report -
Annual Subscription
USD 3,499
tax inclusive*
Detailed Report -
One Time
USD 4,299
tax inclusive*
Detailed Report -
Annual Subscription
USD 7,999
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.